Amedeo Smart

Free Medical Literature Service


 

Amedeo

Influenza

  Free Subscription

04.07.2022

1 Arch Virol
2 BMC Pediatr
5 BMJ
1 Cell
2 Epidemiol Infect
1 J Gen Virol
1 J Infect Dis
8 JAMA
5 Lancet
3 MMWR Morb Mortal Wkly Rep
3 PLoS Comput Biol
1 PLoS Med
26 PLoS One
9 Proc Natl Acad Sci U S A
1 Virology



    Arch Virol

  1. NAGY A, Stara M, Vodicka R, Cernikova L, et al
    Reverse-zoonotic transmission of SARS-CoV-2 lineage alpha (B.1.1.7) to great apes and exotic felids in a zoo in the Czech Republic.
    Arch Virol. 2022;167:1681-1685.
    >> Share


    BMC Pediatr

  2. DAI S, Li J, Li J, Li L, et al
    Analysis of 4 cases of children with false-positive results of novel coronavirus-specific antibody.
    BMC Pediatr. 2022;22:372.
    >> Share

  3. KAFINTU-KWASHIE AA, Nii-Trebi NI, Obodai E, Neizer M, et al
    Molecular epidemiological surveillance of viral agents of acute lower respiratory tract infections in children in Accra, Ghana.
    BMC Pediatr. 2022;22:364.
    >> Share


    BMJ

  4. STOKEL-WALKER C
    How long does SARS-CoV-2 stay in the body?
    BMJ. 2022;377:o1555.
    >> Share

  5. WISE J
    Covid-19: Pausing immune suppressing drugs enhances antibody response to boosters, study shows.
    BMJ. 2022;377:o1586.
    >> Share

  6. WISE J
    Covid-19: UK makes first payments to compensate injury or death from vaccines.
    BMJ. 2022;377:o1565.
    >> Share

  7. KARAN A
    The covid-19 pandemic will end with public health tools, not clinical ones.
    BMJ. 2022;377:o1561.
    >> Share

  8. TANNE JH
    Covid-19 failures show the US needs a national public health system, commission finds.
    BMJ. 2022;377:o1552.
    >> Share


    Cell

  9. XU K, Gao P, Liu S, Lu S, et al
    Protective prototype-Beta and Delta-Omicron chimeric RBD-dimer vaccines against SARS-CoV-2.
    Cell. 2022;185:2265-2278.
    >> Share


    Epidemiol Infect

  10. JUDSON SD, Torimiro J, Pigott DM, Maima A, et al
    COVID-19 data reporting systems in Africa reveal insights for future pandemics.
    Epidemiol Infect. 2022;150:e119.
    >> Share

  11. SCHULMAN A, Bhanot G
    Using postal change-of-address data to predict second waves in infections near pandemic epicentres.
    Epidemiol Infect. 2022;150:e120.
    >> Share


    J Gen Virol

  12. LIU L, Weiss A, Saul VV, Schermuly RT, et al
    Comparative kinase activity profiling of pathogenic influenza A viruses reveals new anti- and pro-viral protein kinases.
    J Gen Virol. 2022;103.
    >> Share


    J Infect Dis

  13. TEMPLE DS, Hegarty-Craver M, Furberg RD, Preble EA, et al
    Wearable sensor-based detection of influenza in presymptomatic and asymptomatic individuals.
    J Infect Dis. 2022 Jun 27. pii: 6618641. doi: 10.1093.
    >> Share


    JAMA

  14. RUDYM D, Chang SH, Angel LF
    Characteristics and Outcomes of Patients With COVID-19-Associated ARDS Who Underwent Lung Transplant.
    JAMA. 2022;327:2454.
    >> Share

  15. MANERIKAR A, Budinger GRS, Bharat A
    Characteristics and Outcomes of Patients With COVID-19-Associated ARDS Who Underwent Lung Transplant-Reply.
    JAMA. 2022;327:2454-2455.
    >> Share

  16. RUBIN R
    From Positive to Negative to Positive Again-The Mystery of Why COVID-19 Rebounds in Some Patients Who Take Paxlovid.
    JAMA. 2022 Jun 8. pii: 2793357. doi: 10.1001/jama.2022.9925.
    >> Share

  17. DEL RIO C, Malani PN
    COVID-19 in 2022-The Beginning of the End or the End of the Beginning?
    JAMA. 2022 May 27. pii: 2793011. doi: 10.1001/jama.2022.9655.
    >> Share

  18. LEVY N, Koppel JH, Kaplan O, Yechiam H, et al
    Severity and Incidence of Multisystem Inflammatory Syndrome in Children During 3 SARS-CoV-2 Pandemic Waves in Israel.
    JAMA. 2022 May 19. pii: 2792718. doi: 10.1001/jama.2022.8025.
    >> Share

  19. KATZ SE, Edwards K
    Protecting Children Against Omicron.
    JAMA. 2022;327:2195-2197.
    >> Share

  20. DORABAWILA V, Hoefer D, Bauer UE, Bassett MT, et al
    Risk of Infection and Hospitalization Among Vaccinated and Unvaccinated Children and Adolescents in New York After the Emergence of the Omicron Variant.
    JAMA. 2022 May 13. pii: 2792525. doi: 10.1001/jama.2022.7319.
    >> Share

  21. PETTY LA, Malani PN
    Oral Antiviral Medications for COVID-19.
    JAMA. 2022 Apr 25. pii: 2791780. doi: 10.1001/jama.2022.6876.
    >> Share


    Lancet

  22. MORGAN R, Pimenta DN, Rashid S
    Gender equality and COVID-19: act now before it is too late.
    Lancet. 2022 Mar 2. pii: S0140-6736(22)00278.
    >> Share

  23. FLOR LS, Friedman J, Spencer CN, Cagney J, et al
    Quantifying the effects of the COVID-19 pandemic on gender equality on health, social, and economic indicators: a comprehensive review of data from March, 2020, to September, 2021.
    Lancet. 2022 Mar 2. pii: S0140-6736(22)00008.
    >> Share

  24. SHIODA K, Lopman B
    How to interpret the total number of SARS-CoV-2 infections.
    Lancet. 2022 Apr 8. pii: S0140-6736(22)00629.
    >> Share


  25. Estimating global, regional, and national daily and cumulative infections with SARS-CoV-2 through Nov 14, 2021: a statistical analysis.
    Lancet. 2022 Apr 8. pii: S0140-6736(22)00484.
    >> Share

  26. BURKI T
    COVID-19 in North Korea.
    Lancet. 2022;399:2339.
    >> Share


    MMWR Morb Mortal Wkly Rep

  27. MALDEN DE, Hong V, Lewin BJ, Ackerson BK, et al
    Hospitalization and Emergency Department Encounters for COVID-19 After Paxlovid Treatment - California, December 2021-May 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:830-833.
    >> Share

  28. DINENNO EA, Delaney KP, Pitasi MA, MacGowan R, et al
    HIV Testing Before and During the COVID-19 Pandemic - United States, 2019-2020.
    MMWR Morb Mortal Wkly Rep. 2022;71:820-824.
    >> Share

  29. GOLD JAW, Kelleher J, Magid J, Jackson BR, et al
    Dispensing of Oral Antiviral Drugs for Treatment of COVID-19 by Zip Code-Level Social Vulnerability - United States, December 23, 2021-May 21, 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:825-829.
    >> Share


    PLoS Comput Biol

  30. MAKOWSKI EK, Schardt JS, Smith MD, Tessier PM, et al
    Mutational analysis of SARS-CoV-2 variants of concern reveals key tradeoffs between receptor affinity and antibody escape.
    PLoS Comput Biol. 2022;18:e1010160.
    >> Share

  31. SCHNEIDER T, Dunbar ORA, Wu J, Bottcher L, et al
    Epidemic management and control through risk-dependent individual contact interventions.
    PLoS Comput Biol. 2022;18:e1010171.
    >> Share

  32. VALLES TE, Shoenhard H, Zinski J, Trick S, et al
    Networks of necessity: Simulating COVID-19 mitigation strategies for disabled people and their caregivers.
    PLoS Comput Biol. 2022;18:e1010042.
    >> Share


    PLoS Med

  33. CUIJPERS P, Heim E, Abi Ramia J, Burchert S, et al
    Effects of a WHO-guided digital health intervention for depression in Syrian refugees in Lebanon: A randomized controlled trial.
    PLoS Med. 2022;19:e1004025.
    >> Share


    PLoS One

  34. TARRY H, Vezina V, Bailey J, Lopes L, et al
    Political orientation, moral foundations, and COVID-19 social distancing.
    PLoS One. 2022;17:e0267136.
    >> Share

  35. BEATTIE RE, Blackwood AD, Clerkin T, Dinga C, et al
    Evaluating the impact of sample storage, handling, and technical ability on the decay and recovery of SARS-CoV-2 in wastewater.
    PLoS One. 2022;17:e0270659.
    >> Share

  36. AKHTAR N, Abid F, Singh R, Kamran S, et al
    Ischemic stroke in patients that recover from COVID-19: Comparisons to historical stroke prior to COVID-19 or stroke in patients with active COVID-19 infection.
    PLoS One. 2022;17:e0270413.
    >> Share

  37. DESALEGN M, Garoma G, Tamrat H, Desta A, et al
    The prevalence of AstraZeneca COVID-19 vaccine side effects among Nigist Eleni Mohammed memorial comprehensive specialized hospital health workers. Cross sectional survey.
    PLoS One. 2022;17:e0265140.
    >> Share

  38. BELETE AM, Alemagegn A, Mulu AT, Yazie TS, et al
    Prevalence of depression and associated factors among adult cancer patients receiving chemotherapy during the era of COVID-19 in Ethiopia. Hospital-based cross-sectional study.
    PLoS One. 2022;17:e0270293.
    >> Share

  39. ALJUAID M, Alotair H, Alnajjar F, Alonazi W, et al
    Risk factors associated with in-hospital mortality patients with COVID-19 in Saudi Arabia.
    PLoS One. 2022;17:e0270062.
    >> Share

  40. MUHARAM R, Agiananda F, Budiman YF, Harahap JS, et al
    Menstrual cycle changes and mental health states of women hospitalized due to COVID-19.
    PLoS One. 2022;17:e0270658.
    >> Share

  41. SADA KE, Yamamoto R, Yano A, Miyauchi A, et al
    Bicarbonate concentration as a predictor of prognosis in moderately severe COVID-19 patients: A multicenter retrospective study.
    PLoS One. 2022;17:e0270141.
    >> Share

  42. MILLS DJ, Petrovic J, Mettler J, Hamza CA, et al
    The good, the bad, and the mixed: Experiences during COVID-19 among an online sample of adults.
    PLoS One. 2022;17:e0269382.
    >> Share

  43. GIR E, Teles SA, Menegueti MG, Reis RK, et al
    Factors associated with the diagnosis of COVID-19 among Brazilian health professionals COVID-19 and health professionals.
    PLoS One. 2022;17:e0267121.
    >> Share

  44. CHANO T, Morita SY, Suzuki T, Yamashita T, et al
    Serology suggests adequate safety measures to protect healthcare workers from COVID-19 in Shiga Prefecture, Japan.
    PLoS One. 2022;17:e0270334.
    >> Share

  45. DE JONGE L, van de Schootbrugge-Vandermeer HJ, Breekveldt ECH, Spaander MCW, et al
    Modelling optimal use of temporarily restricted colonoscopy capacity in a FIT-based CRC screening program: Application during the COVID-19 pandemic.
    PLoS One. 2022;17:e0270223.
    >> Share

  46. UMUNNAKWE CN, Makatini ZN, Maphanga M, Mdunyelwa A, et al
    Evaluation of a commercial SARS-CoV-2 multiplex PCR genotyping assay for variant identification in resource-scarce settings.
    PLoS One. 2022;17:e0269071.
    >> Share

  47. LAU VI, Dhanoa S, Cheema H, Lewis K, et al
    Non-COVID outcomes associated with the coronavirus disease-2019 (COVID-19) pandemic effects study (COPES): A systematic review and meta-analysis.
    PLoS One. 2022;17:e0269871.
    >> Share

  48. CERVANTES-LUEVANO K, Espino-Vazquez AN, Flores-Acosta G, Bernaldez-Sarabia J, et al
    Neutralizing antibodies levels are increased in individuals with heterologous vaccination and hybrid immunity with Ad5-nCoV in the north of Mexico.
    PLoS One. 2022;17:e0269032.
    >> Share

  49. ZHANG F, Yu C, Xu W, Li X, et al
    Identification of critical genes and molecular pathways in COVID-19 myocarditis and constructing gene regulatory networks by bioinformatic analysis.
    PLoS One. 2022;17:e0269386.
    >> Share

  50. SIEWCHAISAKUL P, Sarakarn P, Nanthanangkul S, Longkul J, et al
    Role of literacy, fear and hesitancy on acceptance of COVID-19 vaccine among village health volunteers in Thailand.
    PLoS One. 2022;17:e0270023.
    >> Share

  51. ATSAWASUWAN P, Del Campo DM, Del Campo LM, Viana G, et al
    Positivity rates of SAR-CoV-2 infection in orthodontic patients at the orthodontic clinic, University of Illinois Chicago.
    PLoS One. 2022;17:e0270311.
    >> Share

  52. ALAJLAN AA, Mukhtar LE, Almussallam AS, Alnuqaydan AM, et al
    Assessment of disinfectant efficacy in reducing microbial growth.
    PLoS One. 2022;17:e0269850.
    >> Share

  53. RAHMAN MM, Chisty MA, Alam MA, Sakib MS, et al
    Knowledge, attitude, and hesitancy towards COVID-19 vaccine among university students of Bangladesh.
    PLoS One. 2022;17:e0270684.
    >> Share

  54. POONAM PBH, Koscik R, Nguyen T, Rikhi S, et al
    Nitric oxide versus epoprostenol for refractory hypoxemia in Covid-19.
    PLoS One. 2022;17:e0270646.
    >> Share

  55. ABDULLAEV A, Abdurakhimov A, Mirakbarova Z, Ibragimova S, et al
    Genome sequence diversity of SARS-CoV-2 obtained from clinical samples in Uzbekistan.
    PLoS One. 2022;17:e0270314.
    >> Share

  56. LEERS MPG, Deneer R, Mostard GJM, Mostard RLM, et al
    Use of an algorithm based on routine blood laboratory tests to exclude COVID-19 in a screening-setting of healthcare workers.
    PLoS One. 2022;17:e0270548.
    >> Share

  57. HERICHOVA I, Jendriskova S, Pidikova P, Krskova L, et al
    Effect of 17beta-estradiol on the daily pattern of ACE2, ADAM17, TMPRSS2 and estradiol receptor transcription in the lungs and colon of male rats.
    PLoS One. 2022;17:e0270609.
    >> Share

  58. BURGER MN, Mayer M, Steimanis I
    Repeated information of benefits reduces COVID-19 vaccination hesitancy: Experimental evidence from Germany.
    PLoS One. 2022;17:e0270666.
    >> Share

  59. ABO SHAMA NM, Mahmoud SH, Bagato O, AbdElsalam ET, et al
    Incidence and neutralizing antibody seroprevalence of influenza B virus in Egypt: Results of a community-based cohort study.
    PLoS One. 2022;17:e0269321.
    >> Share


    Proc Natl Acad Sci U S A

  60. IOB E, Steptoe A, Zaninotto P
    Mental health, financial, and social outcomes among older adults with probable COVID-19 infection: A longitudinal cohort study.
    Proc Natl Acad Sci U S A. 2022;119:e2200816119.
    >> Share

  61. OSWIN HP, Haddrell AE, Otero-Fernandez M, Mann JFS, et al
    The dynamics of SARS-CoV-2 infectivity with changes in aerosol microenvironment.
    Proc Natl Acad Sci U S A. 2022;119:e2200109119.
    >> Share

  62. MAHAS A, Marsic T, Lopez-Portillo Masson M, Wang Q, et al
    Characterization of a thermostable Cas13 enzyme for one-pot detection of SARS-CoV-2.
    Proc Natl Acad Sci U S A. 2022;119:e2118260119.
    >> Share

  63. BAN DK, Bodily T, Karkisaval AG, Dong Y, et al
    Rapid self-test of unprocessed viruses of SARS-CoV-2 and its variants in saliva by portable wireless graphene biosensor.
    Proc Natl Acad Sci U S A. 2022;119:e2206521119.
    >> Share

  64. HU G, Hamovit N, Croft K, Roberts JD, et al
    Assessing inequities underlying racial disparities of COVID-19 mortality in Louisiana parishes.
    Proc Natl Acad Sci U S A. 2022;119:e2123533119.
    >> Share

  65. KARDAVA L, Rachmaninoff N, Lau WW, Buckner CM, et al
    Early human B cell signatures of the primary antibody response to mRNA vaccination.
    Proc Natl Acad Sci U S A. 2022;119:e2204607119.
    >> Share

  66. BEUCHER G, Blondot ML, Celle A, Pied N, et al
    Bronchial epithelia from adults and children: SARS-CoV-2 spread via syncytia formation and type III interferon infectivity restriction.
    Proc Natl Acad Sci U S A. 2022;119:e2202370119.
    >> Share

  67. SNYDER M, Alburez-Gutierrez D, Williams I, Zagheni E, et al
    Estimates from 31 countries show the significant impact of COVID-19 excess mortality on the incidence of family bereavement.
    Proc Natl Acad Sci U S A. 2022;119:e2202686119.
    >> Share

  68. KAPOOR K, Chen T, Tajkhorshid E
    Posttranslational modifications optimize the ability of SARS-CoV-2 spike for effective interaction with host cell receptors.
    Proc Natl Acad Sci U S A. 2022;119:e2119761119.
    >> Share


    Virology

  69. GUAN M, Jacobson O, Sarafianos G, Baroch J, et al
    Exposure of white-tailed deer in North America to influenza D virus.
    Virology. 2022;573:111-117.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016